The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,445,203 in first-year total cost, median $6,445,203.
Most frequent study sections
- Medication Development Research Study Section[NIDA-L]1
Most frequent institutions
- SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Characterization, optimization, and development of dual mGlu2/3 positive allosteric modulators for opioid use disorder1R01DA057120-01 | COSFORD, NICHOLAS DAVIDGOULD, ROBERT WARRENVELICELEBI, GONUL | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $6,445,203 | NIDA |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.